A phase I study of bi-weekly combination therapy with S-1 and docetaxel for advanced or recurrent gastric cancer.
Year: 2006
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Yokohama City University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: S-1, docetaxel, advanced gastric cancer, recurrent gastric cancer, combination chemotherapy, maximum tolerated dose, dose-limiting toxicity, tegafur, 5-fluorouracil, dihydropyrimidine dehydrogenase inhibition, potassium oxonate, anemia, diarrhea, stomatitis, hematologic toxicity, anticancer activity
Open Access status: closed
OpenAlex ID: W2466607817
